Baxter International Financial Statements
Baxter International Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
© 2009 Morningstar, Inc. Financial Data provided by
Baxter International Income Statement
| 2008 | 2007 | 2006 | |
|---|---|---|---|
| Revenue ($ mil.) | 12,348.0 | 11,263.0 | 10,378.0 |
| Gross Profit ($ mil.) | 6,130.0 | 5,519.0 | 4,737.0 |
| Operating Income ($ mil.) | 2,599.0 | 2,238.0 | 1,847.0 |
| Total Net Income ($ mil.) | 2,014.0 | 1,707.0 | 1,397.0 |
| Diluted EPS (Net Income) | 3.16 | 2.61 | 2.13 |
Baxter International Quarterly Statements
| Quarter Ending Sep 09 | Quarter Ending Jun 09 | Quarter Ending Jun 09 | |
|---|---|---|---|
| Revenue ($ mil.) | 3,145.0 | 3,123.0 | 3,123.0 |
| Gross Profit ($ mil.) | 1,632.0 | 1,638.0 | 1,638.0 |
| Operating Income ($ mil.) | 681.0 | 748.0 | 748.0 |
| Total Net Income ($ mil.) | 530.0 | 589.0 | 589.0 |
| Diluted EPS (Net Income) | 0.87 | 0.96 | 0.96 |
Baxter International Stock Quote & Chart
11/06/09 16:00:16 EST •
NYSE •
55.12
•
 +0.2800
•
+0.5106 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Baxter International Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 2.79 | 2.38 | 7.01 |
| Price/Earnings Ratio | 15.48 | 27.93 | 25.51 |
| Price/Book Ratio | 4.69 | 2.79 | 6.74 |
| Price/Cash Flow Ratio | 13.40 | 12.82 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Baxter International Financial Ratios
Baxter International Competitive Intelligence
| Bayer HealthCare | CSL Behring | Talecris | |
|---|---|---|---|
| Annual Sales ($ mil.) | 20,814.9 | 0.0 | 1,374.3 |
| Employees | 53,100 | 5,800 | 4,763 |
| Market Cap ($ mil.) | -- | -- | 2,386.1 |
Competitive Landscape
